Stockholders' Equity (Tables)

12 Months Ended

Mar. 31, 2022

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of stock option activity and related information [Table Text Block]

	Number		Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
Outstanding as of March 31, 2021 and 2020	-	$	-	-	$	-
Stock options issued on acquisition of NCI	3,349,375		4.06	4.12		3,166,100
Outstanding as of March 31, 2022	3,349,375	$	4.06	4.12	$	3,166,100
Options exercisable as of March 31, 2022	1,645,625	$	3.32	4.04	$	2,765,200

Schedule of options outstanding [Table Text Block]

Number of options	Exercise price		Remaining life	Expiry date
			(years)
75,000	$	0.32	2.76	January 1, 2025
718,750	$	1.92	3.96	March 15, 2026
2,055,625	$	4.76	4.13	May 17, 2026
200,000	$	5.09	4.46	September 13, 2026
300,000	$	4.64	4.56	October 18, 2026
3,349,375

Schedule of changes of warrant activities [Table Text Block]

	Warrants		Weighted average exercise price
Balance, March 31, 2020	-	$	-
Issued	7,363,193		2.08
Balance, March 31, 2021	7,363,193	$	2.08
Issued	252,525		2.08
Balance, March 31, 2022	7,615,718	$	2.08

DTRC [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of stock option activity and related information [Table Text Block]

	Number			Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
Outstanding as of October 15, 2020	2,062,500		$	0.32	4.13	$	2,146,000
Options granted	750,000			1.92	4.96		-
Options exercised	(1,987,500	)		0.32	-		3,635,688
Outstanding as of March 31, 2021	825,000		$	1.77	4.86	$	285,000
Options granted	2,571,250			4.77
Options expired	(5,208	)		-
Options forfeited/cancelled	(41,667	)		2.63
Outstanding as of March 31, 2022	3,349,375		$	4.06	4.12	$	3,166,100
Canceled on acquisition of NCI	(3,349,375	)
Outstanding as of March 31, 2022	-			-	-		-